Hereditary ovarian carcinoma. Biomarker studies

Area of Science:

• Genetics
• Oncology
• Biochemistry

Background:

• Ovarian carcinoma exhibits familial clustering, suggesting a genetic component.
• Identical twins concordant for ovarian cancer provide unique insights into genetic and environmental factors.
• Understanding inheritance patterns is crucial for identifying at-risk individuals.

Purpose of the Study:

• To investigate the inheritance pattern of ovarian cancer in hereditary cancer-prone kindreds.
• To identify potential biomarkers for early detection and risk stratification in ovarian cancer.
• To explore the role of in vitro hyperdiploidy and alpha-L-fucosidase levels in ovarian cancer predisposition.

Main Methods:

• Medical-genetic surveys including detailed questionnaires and retrieval of medical/pathology documents.
• Analysis of ovarian cancer transmission patterns within three kindreds.
• Determination of in vitro hyperdiploidy in dermal monolayer cultures.
• Measurement of serum alpha-L-fucosidase levels in affected individuals, at-risk relatives, and controls.

Main Results:

• Ovarian carcinoma demonstrated vertical transmission consistent with autosomal dominant inheritance in all three families.
• Lower serum alpha-L-fucosidase levels (<= 275 IU/ml) were observed in all cancer-affected patients.
• Statistically significant lower serum alpha-L-fucosidase levels were found in 50% risk individuals compared to controls (P=0.04 and P=0.0002).
• In vitro hyperdiploidy was assessed as a potential biomarker.

Conclusions:

• The findings support an autosomal dominant inheritance model for ovarian cancer in these kindreds.
• Serum alpha-L-fucosidase levels and in vitro hyperdiploidy show potential as biomarkers for ovarian cancer risk assessment.
• Development of a risk factor profile could enable targeted surveillance and management programs for high-risk individuals.